Our data point to the conversion of established EMT status of the aggressive breast cancer cells MCF-7/SP10+ and MDA-MB-231 into a more epithelial-like state, triggered by the treatment of cells with lumican and the knockdown of ERα and the suppression of ERβ, respectively. Here, ESR2 is linked to breast carcinoma.